ResearchSafe

NA-Selank (N-Acetyl Selank (Acetylated Selank))

Category: Cognitive & Nootropic. Status: Research compound.

An acetylated form of Selank with improved stability and enhanced bioavailability. Same anxiolytic and cognitive benefits with longer duration.

How it works

Same tuftsin-derived mechanism as Selank with acetyl group providing protease resistance; modulates GABA, enhances BDNF.

Key facts

  • Molecular weight: 793.91 Da
  • Half-life: ~5-10 minutes (effective 4-6 hours)
  • Bioavailability: ~95% intranasal
  • Storage: Refrigerated 2-8°C.

Dosing overview

  • Typical dose: 200-400 mcg
  • Frequency: 1-2x daily
  • Duration: 2-4 weeks
  • Route: Intranasal spray

Protocol notes

  • Typical use is 1-2 nasal sprays delivering ~200-400 mcg total per dose, once or twice daily.
  • Many use it situationally for acute anxiety/focus rather than around the clock.
  • The acetylated form lasts longer than regular Selank, so fewer daily doses are usually needed.

Reported benefits

  • Enhanced anxiolytic effect
  • Improved stability
  • Better bioavailability
  • Cognitive focus
  • Stress resilience

Possible side effects

  • Nasal irritation
  • Mild sedation (rare)
  • Headache

Research

  • N-Acetyl peptide modifications (2019): Acetylation extended effective half-life by 3-4x and improved BBB penetration.
  • Modified tuftsin analogs for anxiety (2020): NA-Selank showed 40% greater anxiolytic potency than Selank.

Compare NA-Selank

Community discussions about NA-Selank

Research and educational reference only. Not medical advice.